Joseph Bauer Email & Phone Number

Our Team focused on improving the cost-effectiveness and evaluating the positive and supportive impacts on health outcomes of programs, services, and treatments at the Levine Cancer Institute (LCI), a patient-centric cancer research hospital. We conducted robust economic outcome evaluations to inform decisions intended to improve healthcare and to provide support for health outcomes research. Our HEOR Team utilized a variety of approaches to analyze the operational, methodological, and policy challenges which are useful to oncology researchers and clinicians conducting studies and to the various decision-makers assessing costs of implementation. Economic evaluation often involves a comparative analysis of alternative courses of action. At LCI we provide strategic and analytical thought leadership for oncological therapeutics where the health outcomes of patients are evaluated in areas such as Supportive Oncology, Pharmacoeconomics, Financial Toxicity, Outreach Services, and other areas. Our challenge was demonstrating the value of interventions within clinical departments with a focus on outcomes meaningful to payers, clinical decision-makers, patients, and fiscal/business decision-makers at LCI. The environment our Team operated in faced many emerging challenges in the healthcare/ health insurance industry, such as: the increasing costs of pharmaceutical drugs, the applications of new technologies to treatment, which equates to increasing costs for patients, the impacts of social determinants of health (SDoH) and their impact on health disparities and health outcomes, and how all of these dynamics increasingly impact financial distress and toxicity of patients. Any organizational project that deals with economics, also deals with politics, and that was an aspect we always had to navigate. While these challenges are all very daunting, our Team strove to make a difference for patients and improve their health care trajectories and health care outcomes.

College Park, Md, Us

As the Quantitative Research Editor, I am responsible for primarily considering the methods and materials section of manuscripts that have gone through peer review to include sample size, study design, analysis of data, documentation and presentation of results and make a decision on whether or not to recommend publication.

Chicago, Il, Us

Directed a team of Advanced Practice Pharmacists committed to building partnerships across multiple disciplinary fields internally and externally (community, academic, and industry). This approach was designed to build an integrated, collaborative team with subject matter experts, to develop. design. and implement best evidence-based practice interventions and achieve improved health outcomes. Our team leveraged innovative problem-solving to achieve value-based, effective care for our members, while trying to control overall costs. Some of our tasks were to: collaboratively develop risk-stratification modelling to be able to predict health outcomes and to be able to triage cost-effective intervention efforts; create real-world evidence-based outcomes value-tracking for the purpose of having a standardized metric to answer the question-‘What outcome are we getting, for what we are spending?’; identifying key strategic partnerships and acting as a bridge between groups for real world data sets; developing real world evidence disease-based data-buckets to assist the development of needed products and to assist sales of medical and pharmaceutical benefits offerings; tracking specific specialty drugs and their outcomes – to derive overall value; investigating industry need and utilization (valuation) of the Organization’s real world data; and deriving new metrics and assisting in the implementation and evaluation of a more cost-effective Pharmaceutical Care Management intervention.The environment our team operated in faced many emerging challenges in the healthcare/health insurance industry, such as: the increasing costs of pharmaceutical drugs, the constant application of new technologies to treatment, and a complex interplay between Big Data, Data Science, and Analytics for every facet of the clinical/operational realm. Ultimately, the goal was to remain member/patient-centric in a system driven by large-scale forces.

Washington, Dc, Us

Judged by PCORI (Patient-Centered Outcomes Research Institute) and the Center for Scientific Review (NIH) as a 'highly qualified' Scientific Reviewer for the inaugural Pilot Projects Grant Program. Have been a Chair/ Reviewer since the inception of PCORI. The pilot project program informs PCORI national priorities, the research agenda, and advances the methodologies of patient-centered outcomes research via comparative effectiveness methodologies. Since 2014, I have also been a Scientific Reviewer for PCORI's large-scale Pragmatic Clinical Studies. Representing the American Cancer Society (ACS) and the Statistics & Evaluation Center (SEC).

Bethesda, Md, Us

Judged by the Center for Scientific Review (CSR) as a 'highly qualified' Scientific Reviewer - eligible for NIH Study Sections and Special Emphasis Panels. In 2013 - invited to be a Distinguished Editor to Review NIH/FDA P50 grants for Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act. Our group of experts from across the country convened in Washington, DC to scientifically review approximately four dozen TCORS proposals utilizing NIH's electronic Research Administration (eRA) Commons. Represented the American Cancer Society (ACS) and the Statistics & Evaluation Center (SEC).

Atlanta, Ga, Us

Was the Interim Vice President of the Statistics & Evaluation Center (SEC) at the American Cancer Society's Global Headquarters in Atlanta, Georgia - my mission and focus was to innovatively lead our Intramural Research Department team in facing the challenges of doing our very best for cancer patients, caregivers, and survivors and for our Organization.From its inception in 2005, the SEC has implemented innovative and multi-disciplinary research approaches, that have greatly improved the Society’s ability to identify, target, and deliver services, identify barriers, and provide better access to quality health care for those people most in need. The SEC has expertise in the social, behavioral, statistical, geospatial, medical, health, and epidemiological sciences, giving them the disciplinary depth and breadth to consult with colleagues from across the Society, including all departments and Senior Leadership at our Global Headquarters in Atlanta, Georgia, the six Regions(nation-wide), the National Cancer Information Center(NCIC) in Austin, Texas, and the American Cancer Society Cancer Action Network (ACS CAN) in Washington, DC. Our Department has become well-recognized and respected for its innovative problem-solving, integrity, transparency, and the ability to deliver evidence-based results with accurate measures of reliability and confidence. The SEC focuses on increasing program impact in a cost-effective manner, supports, and guides evidence-based decisions at all levels of the American Cancer Society.

Atlanta, Ga, Us

Provided strategic and operational leadership and expertise for the Statistics & Evaluation Center (SEC). Directs the Statistics & Evaluation Center – Survey Resource (SEC-SR) and the Design Research Center for Cognitive & Usability Testing (DRC-CUT). He led the Society’s important evaluations that improve mission-delivery and positively impacts the lives of cancer patients, caregivers, survivors, as well as members of the general population. He is a design thinker, designer, and creative problem-solver. He studies user experience (UX), user testing (UT), and user design (UD), as they apply to creating more effective systems and processes. He is a seasoned consultant who has significant breadth and depth in several disciplinary areas, which span the social, behavioral, health, statistical, and epidemiological sciences. He has expertise in survey research, evaluation, biostatistics, research methodology, testing and study design, measurement science, dissemination and implementation science, and gerontology. He has extensive experience in conducting evaluations in the areas of learning/ training design, cancer control, healthy communities (built environment), health promotion, health education, global health, community- and hospital-based research, population-based dissemination & implementation science, large scale pragmatic clinical trials, and is very adept at strategic thinking and planning to improve business metrics and achieve Organizational goals.

Washington, D.C., Dc, Us

This Section of the Journal presents reports of evaluation work that is both thought provoking, and in some way, considered exemplary. All forms of evaluation practice - formative or summative, domestic or international, and evaluations conducted in any professional or disciplinary setting - are suitable for consideration. Represented the American Cancer Society (ACS), Intramural Research, and the Statistics & Evaluation Center (SEC).

Washington, D.C., Dc, Us

Professional collaboration with national colleagues. Primarily responsible for setting up our Topical Interest group's (TIG) programs for three years - at the National Conference in Anaheim, Minneapolis, and Washington, DC venues. Led the strategic evolution of our 1,000+ member group for three years, as we implemented tactics that furthered the development of knowledge and understanding of organizational learning and evaluation capacity building. We evolved several capacity-building opportunities with the Local Affiliate Collaborative (LAC), to expand and strengthen a national evaluation community of practice. I transitioned to the Leadership Team for our TIG. Represented the American Cancer Society (ACS), Intramural Research, and the Statistics & Evaluation Center (SEC).

Oakland, California, Us

Invited Scientific Reviewer for the Tobacco-Related Disease Research Program ((TRDRP) - University of California - Office of the President. Policy, Regulatory Sciences, & Exposure Measurement Study Section. Each year, tobacco control/ policy/ exposure/ regulatory science experts from across the country review approximately two dozen RO1-like proposals and participate in an on-line peer-review process, utilizing ProposalCentral. Representing the American Cancer Society (ACS) and the Statistics & Evaluation Center (SEC).

Atlanta, Ga, Us

I am qualified to teach biostatistics as it is applied to clinical and population-based problem-solving. I recruit student interns to assist the Statistics & Evaluation Center (SEC) at the American Cancer Society (ACS) in the provision of evaluation services. This opportunity provides them with a learning environment, job experience, and opportunity to publish to better position them for future employment. I have mentored about a dozen interns over the years in designing and implementation of 'real world' evaluation studies. I have an extensive teaching portfolio - having both undergraduate and graduate school experience, primarily with Gerontology/Aging, Research Methods/ Study Design, and Statistics (Applications in Behavioral, Epidemiological, Health and Social Sciences)

Buffalo, Ny, Us

Developed an NCI - Core Resource at a Comprehensive Cancer Center. As the Founding Director - I was responsible for building a program that produced high quality science (NIH-level grants), while saving hundreds of thousands of dollars in sub-contracting costs for the Department each year. The mantra of our Resource was - 'The Best Information Produces the Best Science!' That translates into not cutting corners and being very meticulous and steadfast in capturing data/information. It served everyone well - translating into millions of dollars in NIH and other State and Foundation grants, and multiple peer-reviewed journal articles and presentations at National Conferences. I was also the Lead Senior Biostatistician on dozens of population- and clinical-based projects. Primary Investigator or Co-Investigator on approximately 7 million dollars in research. I was a member of the Institutional Review Board (IRB) and the Continuing Medical Education (CME) Board. I was also an adjunct Associate Professor teaching courses in the Roswell Park Cancer Institute Graduate Division.

Buffalo, Ny, Us

Evaluation of Undergraduate, Graduate, and Continuing Medical Education curriculums. Research and development of 'standardized patient' models with evaluation overlays for clinical training of undergraduate and graduate medical students. Created several Objective Structured Clinical Exams (OSCE's) for the Clinical Practice of Medicine courses. Leader on Dean's Blue Ribbon Committee for Medical Education Curriculum Re-design with Problem-Based Learning (PBL). I was a School of Medicine Faculty PBL Facilitator for First and Second year students, and Faculty Leader on Graduate Medical Education; certified in Evidence-Based Medicine, Population-Based Medicine, Research and Statistics, and Ethics. Developed multi-disciplinary PBL course in palliative care that included health professional students from the Schools of Nursing, Social Work, Pharmacy, and Medicine. Liaisoned with Deans of all Schools to cross-list this into the education curriculums.

Buffalo, New York, Us

I provided study design, bio-statistical analysis, evaluation, and reporting for a number of Phase IV population-based clinical trials for Pharma-funded studies. I also, managed and evaluated a Phase III population-based drug efficacy study and a cognitive study of post-operative breast cancer patients.

Phd (1992), Gerontology, Medical Sociology, Health Behavior, Health Communications, Statistics/Research Methods

Education record